Correlation between quantitative HER2 protein level and pathologic complete response (pCR) in HER2-positive (+) breast cancer patients (pts) treated with neoadjuvant (NEO) dose-dense (dd) chemotherapy plus trastuzumab

Journal article

Peer reviewed

J. Hurley, C. Welsh, A. C. Fort, J. Weidler, A. Paquet, W. Huang, Y. Lie, S. Gupta, M. P. Bates and M. D. Pegram

Journal of clinical oncology, Vol.28(15_suppl), pp.586-586

2010-05-20

Metrics

3 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Correlation between quantitative HER2 protein level and pathologic complete response (pCR) in HER2-positive (+) breast cancer patients (pts) treated with neoadjuvant (NEO) dose-dense (dd) chemotherapy plus trastuzumab
Creators: J. Hurley
C. Welsh
A. C. Fort
J. Weidler
A. Paquet
W. Huang
Y. Lie
S. Gupta
M. P. Bates
M. D. Pegram
Publication Details: Journal of clinical oncology, Vol.28(15_suppl), pp.586-586
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031740304002976